This week, we submitted comments relating to the efficacy and medical usefulness of cannabis as a medical treatment. In early April, the Food and Drug Administration (FDA) issued a notice in the federal register asking for public comments on cannabis and its derivatives. These comments will help inform the response of the United States to the World Health Organization in potentially reclassifying cannabis.
Source: http://www.safeaccessnow.org/fda_comments_2018
ASA Submits Recommendations to FDA for International Rescheduling of Cannabis is courtesy of The Giggles N Dimples Blog
source https://gigglesndimples.com/2018/04/23/asa-submits-recommendations-to-fda-for-international-rescheduling-of-cannabis/
No comments:
Post a Comment